Global Acetaminophen Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Acetaminophen Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Acetaminophen Injection, also known as Paracetamol Injection, is a sterile, clear, colorless, non-pyrogenic, isotonic formulation of acetaminophen intended for intravenous infusion. Acetaminophen injection is used to relieve mild to moderate pain and to reduce fever. Acetaminophen injection is also used in combination with opioid (narcotic) medications to relieve moderate to severe pain. Acetaminophen is in a class of medications called analgesics (pain relievers) and antipyretics (fever reducers). It works by changing the way the body senses pain and by cooling the body.
Acetaminophen Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Acetaminophen Injection market is projected to reach US$ 1099.9 million in 2034, increasing from US$ 992.5 million in 2022, with the CAGR of 1.5% during the period of 2024 to 2034. Demand from Adult Use and Pediatric Use are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Acetaminophen Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Acetaminophen Injection key manufacturers include Mallinckrodt Pharmaceuticals, B. Braun Medical Inc, Leucadia Pharmaceuticals, AuroMedics Pharma LLC, Sandoz AG, Fresenius Kabi, Perrigo Company plc, Terumo Corporation and AdvaCare Pharma, etc. Mallinckrodt Pharmaceuticals, B. Braun Medical Inc, Leucadia Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Acetaminophen Injection can be divided into 150mg/1mL, 300mg/2mL, 500mg/50 mL and 1000mg/100 mL, etc. 150mg/1mL is the mainstream product in the market, accounting for % sales share globally in 2022.
Acetaminophen Injection is widely used in various fields, such as Adult Use, Pediatric Use and Geriatric Use,, etc. Adult Use provides greatest supports to the Acetaminophen Injection industry development. In 2022, global % sales of Acetaminophen Injection went into Adult Use filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Acetaminophen Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Mallinckrodt Pharmaceuticals
B. Braun Medical Inc
Leucadia Pharmaceuticals
AuroMedics Pharma LLC
Sandoz AG
Fresenius Kabi
Perrigo Company plc
Terumo Corporation
AdvaCare Pharma
Accord Healthcare
Pfizer
Tylenol
Aeknil
DINAMIS HEALTHCARE INC
Segment by Type
150mg/1mL
300mg/2mL
500mg/50 mL
1000mg/100 mL
Adult Use
Pediatric Use
Geriatric Use
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Acetaminophen Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Acetaminophen Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Acetaminophen Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Acetaminophen Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Acetaminophen Injection introduction, etc. Acetaminophen Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Acetaminophen Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Acetaminophen Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Acetaminophen Injection market is projected to reach US$ 1099.9 million in 2034, increasing from US$ 992.5 million in 2022, with the CAGR of 1.5% during the period of 2024 to 2034. Demand from Adult Use and Pediatric Use are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Acetaminophen Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Acetaminophen Injection key manufacturers include Mallinckrodt Pharmaceuticals, B. Braun Medical Inc, Leucadia Pharmaceuticals, AuroMedics Pharma LLC, Sandoz AG, Fresenius Kabi, Perrigo Company plc, Terumo Corporation and AdvaCare Pharma, etc. Mallinckrodt Pharmaceuticals, B. Braun Medical Inc, Leucadia Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Acetaminophen Injection can be divided into 150mg/1mL, 300mg/2mL, 500mg/50 mL and 1000mg/100 mL, etc. 150mg/1mL is the mainstream product in the market, accounting for % sales share globally in 2022.
Acetaminophen Injection is widely used in various fields, such as Adult Use, Pediatric Use and Geriatric Use,, etc. Adult Use provides greatest supports to the Acetaminophen Injection industry development. In 2022, global % sales of Acetaminophen Injection went into Adult Use filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Acetaminophen Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Mallinckrodt Pharmaceuticals
B. Braun Medical Inc
Leucadia Pharmaceuticals
AuroMedics Pharma LLC
Sandoz AG
Fresenius Kabi
Perrigo Company plc
Terumo Corporation
AdvaCare Pharma
Accord Healthcare
Pfizer
Tylenol
Aeknil
DINAMIS HEALTHCARE INC
Segment by Type
150mg/1mL
300mg/2mL
500mg/50 mL
1000mg/100 mL
Segment by Application
Adult Use
Pediatric Use
Geriatric Use
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Acetaminophen Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Acetaminophen Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Acetaminophen Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Acetaminophen Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Acetaminophen Injection introduction, etc. Acetaminophen Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Acetaminophen Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices